Patients File Class Action Xarelto Lawsuit in Canada

March 26, 2016 – – BloodThinnerHelp.com reports on the Calgary Sun’s article concerning Canadian patients who have filed Xarelto lawsuits. The lead plaintiff in Canada’s class action suit alleges that she suffered uncontrollable bleeding after taking Xarelto in 2012. She claims that after doctors struggled to control the bleeding, she went into cardiac arrest.

The Canadian class action suit against the blood-thinning drug, manufactured by Johnson & Johnson and Bayer, came about a year after a multidistrict litigation panel was formed in the U.S. for similar cases. As of March 2015, Health Canada received about 1,100 reports of adverse side effects believed to be related to Xarelto. Multidistrict litigation No. 2592 in the U.S. has reached almost 3,000 cases and a smaller group of filings consolidated by the Philadelphia Court of Common Pleas into a mass tort program for cases filed in the Commonwealth of Pennsylvania has hit 620 cases.

Xarelto was first approved by the FDA in 2011 for preventing blood clots in deep vein thrombosis patients undergoing knee and hip replacements, atrial fibrillation, and for general use in reducing the recurrence of blood clots, and stent thrombosis in patients with acute coronary syndrome. A phase III study showed that 73 percent of study participants who took Xarelto suffered from an adverse side effect. Commonly reported side effects that have been attributed to the drug by those filing suits are pulmonary embolisms (blood clots in the lung), rectal bleeding, heart attack, stroke, epidural hematoma, internal bleeding, gastrointestinal bleeding and brain hemorrhages.

While thousands of cases against Xarelto manufacturers have already arisen, more are expected to be filed. The statute of limitations on those cases varies by state, usually ranging from two to three years from the time of injury.

As more cases are brought to court, Attorney Joseph Osborne is working to ensure that all those who believe they have been negatively affected by the blood-thinning drug have their questions answered and are able to explore their legal rights. Those individuals could be entitled to legal action and substantial financial compensation. Osborne is currently offering free legal consultations to qualifying individuals.

To request further Xarelto information, or to ask questions, please contact Joseph Osborne at (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60008902